S Hoque

34 papers receiving 517 citations

S Hoque's Hit Papers

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study 2024 · 66 citations
660+1Years since publication204060

Peers

S Hoque
Comparison fields: 5 of 74
  • Genetics 284
  • Gastroenterology 34
  • Immunology 92
  • Endocrinology 19
  • Hematology 37
Replace Almuthe Christina Hauer with:
Almuthe Christina Hauer Austria
Mukesh Kumar Singh India
Claudia Cucino Italy
Emily Tam Nguyen United States
Christian Primas Austria
Jeffrey R. Butterworth United Kingdom
Giulia Angelino Italy
Witold Bartnik Poland
Clara Yzet France
Silvja Cukovic-Cavka Denmark
S Hoque relative to Almuthe Christina Hauer Austria Almuthe Christina Hauer's profile →
Citations per field
00.5×2×4×6×7.3×
Almuthe Christina Hauer · 1×
Citations per year

Countries citing papers authored by S Hoque

Since Specialization
Citations

This map shows the geographic impact of S Hoque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Hoque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Hoque more than expected).

Fields of papers citing papers by S Hoque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Hoque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Hoque. The network helps show where S Hoque may publish in the future.

Co-authors

The 25 scholars most cited alongside S Hoque, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S Hoque Line = papers co-authored together S Hoque links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#Work
1 201381
2
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study
Hit paper breakdown →
202466
3 201659
4 202139
5 201634
6 201228
7 201621
8 202417
9 199216
10 201616
11 201815
12 201515
13 202114
14 199614
15 200013
16 201811
17 202011
18 199710
19 20219
20 20007

About S Hoque

S Hoque is a scholar working on Genetics, Gastroenterology, Hematology, Endocrinology and Immunology, having authored 39 papers that have together received 532 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (17 papers), Microscopic Colitis (4 papers), Viral gastroenteritis research and epidemiology (3 papers), Iron Metabolism and Disorders (3 papers), Gastrointestinal motility and disorders (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Dermatology and Skin Diseases (2 papers) and Colorectal Cancer Screening and Detection (2 papers). The work is most often cited by research in Genetics (284 citations), Gastroenterology (34 citations), Immunology (92 citations), Endocrinology (19 citations) and Hematology (37 citations). S Hoque has collaborated with scholars based in United Kingdom, Bangladesh and United States. Frequent co-authors include Rachel J. Archer, Alan Lobo, Shijie Ren, Paul Tappenden, Dilip Mahalanabis, Rebecca C. Harvey, Marrissa Martyn‐St James, John Stevens, Hasan Basarir and Abu Syed Golam Faruque. Their work appears in journals such as Gastroenterology, Cochrane Database of Systematic Reviews, Diagnostic Microbiology and Infectious Disease, PharmacoEconomics and BMJ Open Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact